Showing results (301-310 of 421) with videos related to

Sort By:
Pageof 43
The Heart Surgery Forum|February 14, 2008
Human leukocyte antigen mismatch and other factors affecting cryopreserved allograft valve functionCheng-Hon Yap, Peter D Skillington, George Matalanis, et al.
BMC Geriatrics|September 15, 2022
The psychosocial health, experiences and needs of older adults and care partners during the first surge of the COVID-19 pandemic: a mixed-methods studyAllison Marziliano, Edith Burns, Taline Pampanini, et al.
The Journal of Heart Valve Disease|August 12, 2006
Anti-HLA antibodies after cryopreserved allograft valve implantation does not predict valve dysfunction at three-year follow upCheng-Hon Yap, Peter D Skillington, George Matalanis, et al.
Tissue Antigens|April 21, 2007
Fourier transform infrared imaging as a method for detection of HLA class I expression in melanoma without the use of antibodyS F Chew, B R Wood, C Kanaan, et al.
The Journal of Clinical Endocrinology and Metabolism|February 26, 2000
Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndromeS F Ahmed, A Cheng, L Dovey, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 24, 2001
A patient with 17 primary tumours and a germ line mutation in TP53: tumour induction by adjuvant therapy?C Nutting, R S Camplejohn, R Gilchrist, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2008
Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?L Wedlake, C McGough, C Hackett, et al.
Bone Marrow Transplantation|May 7, 1999
Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD)S Kulkarni, M Rodriguez, A Lafuente, et al.
Bone Marrow Transplantation|April 28, 1999
Impact of previous high-dose therapy on outcome after allografting for multiple myelomaS Kulkarni, R L Powles, J G Treleaven, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2015
Flt3 Ligand Is Essential for Survival and Protective Immune Responses during ToxoplasmosisChristopher D Dupont, Gretchen Harms Pritchard, Shinya Hidano, et al.
Pageof 43